相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Protease-Activated Receptor Antagonist for Reducing Cardiovascular Events-A Review on Vorapaxar
Rahul Gupta et al.
CURRENT PROBLEMS IN CARDIOLOGY (2023)
Reflection on the Past, Present, and Future of Thrombolytic Therapy for Acute Ischemic Stroke
Stacie L. Demel et al.
NEUROLOGY (2021)
Current status of ischemic stroke treatment: From thrombolysis to potential regenerative medicine
Mason Daniel Hurd et al.
REGENERATIVE THERAPY (2021)
Effects of argatroban therapy for stroke patients: A meta-analysis
Xiaojun Hou et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2021)
Non-immunogenic recombinant staphylokinase versus alteplase for patients with acute ischaemic stroke 4.5 h after symptom onset in Russia (FRIDA): a randomised, open label, multicentre, parallel-group, non-inferiority trial
Eugene Gusev et al.
LANCET NEUROLOGY (2021)
Benefits and Risks of Dual Versus Single Antiplatelet Therapy for Secondary Stroke Prevention: A Systematic Review for the 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
Devin L. Brown et al.
STROKE (2021)
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
Dawn O. Kleindorfer et al.
STROKE (2021)
European Stroke Organisation (ESO) guidelines on the management of space-occupying brain infarction
H. Bart van der Worp et al.
EUROPEAN STROKE JOURNAL (2021)
European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke
Eivind Berge et al.
EUROPEAN STROKE JOURNAL (2021)
European Stroke Organisation expedited recommendation for the use of short-term dual antiplatelet therapy early after minor stroke and high-risk TIA
Jesse Dawson et al.
EUROPEAN STROKE JOURNAL (2021)
Stroke and thromboembolism prevention in atrial fibrillation
Sina Jame et al.
HEART (2020)
Association Between Low-Dose Rivaroxaban With or Without Aspirin and Ischemic Stroke Subtypes A Secondary Analysis of the COMPASS Trial
Kanjana S. Perera et al.
JAMA NEUROLOGY (2020)
Embolic Stroke of Undetermined Source JACC Review Topic of the Week
George Ntaios
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Improved Outcomes after Reperfusion Therapies for Ischemic Stroke: A Real-world Study in a Developing Country
Victor C. Schulz et al.
CURRENT NEUROVASCULAR RESEARCH (2020)
Primary and Secondary Prevention of Ischemic Stroke and Cerebral Hemorrhage
Hans-Christoph Diener et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
The rebirth of the contact pathway: a new therapeutic target
Priyanka Srivastava et al.
CURRENT OPINION IN HEMATOLOGY (2020)
Population Pharmacokinetic/Pharmacodynamic Modeling of Glenzocimab (ACT017) a Glycoprotein VI Inhibitor of Collagen-Induced Platelet Aggregation
Lionel Renaud et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2020)
Ageing as a risk factor for cerebral ischemia: Underlying mechanisms and therapy in animal models and in the clinic
Aurel Popa-Wagner et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2020)
Effect of Pre- and In-Hospital Delay on Reperfusion in Acute Ischemic Stroke Mechanical Thrombectomy
Johannes Kaesmacher et al.
STROKE (2020)
Effectiveness of Platelet Function Analysis-Guided Aspirin and/or Clopidogrel Therapy in Preventing Secondary Stroke: A Systematic Review and Meta-Analysis
Ann-Rong Yan et al.
JOURNAL OF CLINICAL MEDICINE (2020)
The AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenic stroke randomized trial: Rationale and methods
Hooman Kamel et al.
INTERNATIONAL JOURNAL OF STROKE (2019)
MAA868, a novel FXI antibody with a unique binding mode, shows durable effects on markers of anticoagulation in humans
Alexander W. Koch et al.
BLOOD (2019)
Thrombolytic Therapy for Acute Ischemic Stroke: Past and Future
Keita Shibata et al.
CURRENT PHARMACEUTICAL DESIGN (2019)
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society
Craig T. January et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source
H. -C. Diener et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Thrombolysis Guided by Perfusion Imaging up to 9 Hours after Onset of Stroke
H. Ma et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Cerebrovascular Disease Primary and Secondary Stroke Prevention
Fan Z. Caprio et al.
MEDICAL CLINICS OF NORTH AMERICA (2019)
Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
William J. Powers et al.
STROKE (2019)
European Stroke Organisation (ESO) - European Society for Minimally Invasive Neurological Therapy (ESMINT) Guidelines on Mechanical Thrombectomy in Acute Ischaemic StrokeEndorsed by Stroke Alliance for Europe (SAFE)
Guillaume Turc et al.
EUROPEAN STROKE JOURNAL (2019)
Decompressive craniectomy for acute ischemic stroke
Thomas Beez et al.
CRITICAL CARE (2019)
Antithrombotic treatment for secondary prevention of stroke and other thromboembolic events in patients with stroke or transient ischemic attack and non-valvular atrial fibrillation: A European Stroke Organisation guideline
Catharina J. M. Klijn et al.
EUROPEAN STROKE JOURNAL (2019)
Effects of alteplase for acute stroke according to criteria defining the European Union and United States marketing authorizations: Individual-patient-data meta-analysis of randomized trials
Werner Hacke et al.
INTERNATIONAL JOURNAL OF STROKE (2018)
Plasma contact factors as therapeutic targets
Benjamin F. Tillman et al.
BLOOD REVIEWS (2018)
Fibrinolysis: strategies to enhance the treatment of acute ischemic stroke
S. J. Henderson et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial
Philip M. Bath et al.
LANCET (2018)
Current and future antiplatelet therapies: emphasis on preserving haemostasis
James D. McFadyen et al.
NATURE REVIEWS CARDIOLOGY (2018)
MRI-Guided Thrombolysis for Stroke with Unknown Time of Onset
G. Thomalla et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA
S. Claiborne Johnston et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke
B. C. V. Campbell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging
G. W. Albers et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct
R. G. Nogueira et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source
R. G. Hart et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Different doses of tenecteplase vs alteplase in thrombolysis therapy of acute ischemic stroke: evidence from randomized controlled trials
Na Xu et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2018)
Tenecteplase for the treatment of acute ischemic stroke: A review of completed and ongoing randomized controlled trials
Shelagh B. Coutts et al.
INTERNATIONAL JOURNAL OF STROKE (2018)
Reduction of Ischemia Reperfusion-Related Brain Hemorrhage by Stachybotrys Microspora Triprenyl Phenol-7 in Mice With Antioxidant Effects
Yong Huang et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2018)
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
Spencer L. G. James et al.
LANCET (2018)
Catheter ablation of atrial fibrillation is associated with reduced risk of stroke and mortality: A propensity score-matched analysis
Walid Saliba et al.
HEART RHYTHM (2017)
Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial
Nicola Logallo et al.
LANCET NEUROLOGY (2017)
Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease
J. W. Eikelboom et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Randomized, Multicenter Trial of ARTSS-2 (Argatroban With Recombinant Tissue Plasminogen Activator for Acute Stroke)
Andrew D. Barreto et al.
STROKE (2017)
Treatment and Outcome of Hemorrhagic Transformation After Intravenous Alteplase in Acute Ischemic Stroke: A Scientific Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
Shadi Yaghi et al.
STROKE (2017)
Early Recurrence and Major Bleeding in Patients With Acute Ischemic Stroke and Atrial Fibrillation Treated With Non-Vitamin-K Oral Anticoagulants (RAF-NOACs) Study
Maurizio Paciaroni et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
Atrial cardiopathy: a mechanism of cryptogenic stroke
Shadi Yaghi et al.
EXPERT REVIEW OF CARDIOVASCULAR THERAPY (2017)
Malignant MCA Infarction: Pathophysiology and Imaging for Early Diagnosis and Management Decisions
Wolf-Dieter Heiss
CEREBROVASCULAR DISEASES (2016)
Different Antiplatelet Strategies in Patients With New Ischemic Stroke While Taking Aspirin
Joon-Tae Kim et al.
STROKE (2016)
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Paulus Kirchhof et al.
EUROPEAN HEART JOURNAL (2016)
Time to Treatment With Endovascular Thrombectomy and Outcomes From Ischemic Stroke: A Meta-analysis
Jeffrey L. Saver et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Atrial Cardiopathy and Cryptogenic Stroke: A Cross-sectional Pilot Study
Shadi Yaghi et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2016)
Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study
Martin J. O'Donnell et al.
LANCET (2016)
Safety and Preliminary Efficacy of Early Tirofiban Treatment After Alteplase in Acute Ischemic Stroke Patients
Wei Li et al.
STROKE (2016)
Desmoteplase 3 to 9 Hours After Major Artery Occlusion Stroke The DIAS-4 Trial (Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke)
Ruediger von Kummer et al.
STROKE (2016)
Atrial Cardiopathy and Cryptogenic Stroke: A Cross-sectional Pilot Study
Shadi Yaghi et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2016)
Cardiovascular Mortality Associated With 5 Leading Risk Factors: National and State Preventable Fractions Estimated From Survey Data
Shivani A. Patel et al.
ANNALS OF INTERNAL MEDICINE (2015)
Vorapaxar for secondary stroke prevention: perspectives and obstacles
Victor L. Serebruany et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2015)
Safety and efficacy of desmoteplase given 3-9 h after ischaemic stroke in patients with occlusion or high-grade stenosis in major cerebral arteries (DIAS-3): a double-blind, randomised, placebo-controlled phase 3 trial
Gregory W. Albers et al.
LANCET NEUROLOGY (2015)
Recurrent Stroke while on Antiplatelet Therapy
Seby John et al.
NEUROLOGIC CLINICS (2015)
Thrombectomy within 8 Hours after Symptom Onset in Ischemic Stroke
T. G. Jovin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Demographic and Epidemiologic Drivers of Global Cardiovascular Mortality
Gregory A. Roth et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Randomized Assessment of Rapid Endovascular Treatment of Ischemic Stroke
M. Goyal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Endovascular Therapy for Ischemic Stroke with Perfusion-Imaging Selection
B. C. V. Campbell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
A Randomized Trial of Intraarterial Treatment for Acute Ischemic Stroke
O. A. Berkhemer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Efficacy of Antiplatelet Therapy in Secondary Prevention Following Lacunar Stroke Pooled Analysis of Randomized Trials
Chun Shing Kwok et al.
STROKE (2015)
Combined Approach to Lysis Utilizing Eptifibatide and Recombinant Tissue-Type Plasminogen Activator in Acute Ischemic Stroke-Full Dose Regimen Stroke Trial
Opeolu Adeoye et al.
STROKE (2015)
Safety and Tolerability of Desmoteplase Within 3 to 9 Hours After Symptoms Onset in Japanese Patients With Ischemic Stroke
Etsuro Mori et al.
STROKE (2015)
Early Recurrence and Cerebral Bleeding in Patients With Acute Ischemic Stroke and Atrial Fibrillation Effect of Anticoagulation and Its Timing: The RAF Study
Maurizio Paciaroni et al.
STROKE (2015)
Vorapaxar for secondary stroke prevention: perspectives and obstacles
Victor L. Serebruany et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2015)
Recombinant Tissue-Type Plasminogen Activator Plus Eptifibatide Versus Recombinant Tissue-Type Plasminogen Activator Alone in Acute Ischemic Stroke Propensity Score-Matched Post Hoc Analysis
Opeolu Adeoye et al.
STROKE (2015)
Selective depletion of factor XI or factor XII with antisense oligonucleotides attenuates catheter thrombosis in rabbits
Jonathan W. Yau et al.
BLOOD (2014)
Inhibition of Factor XI activity as a promising antithrombotic strategy
Zhu Chen et al.
DRUG DISCOVERY TODAY (2014)
Intravenous thrombolysis in acute ischemic stroke: standard and potential future applications
Michal Harsany et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2014)
Novel oral anticoagulants: A focused review for stroke physicians
Emer R. McGrath et al.
INTERNATIONAL JOURNAL OF STROKE (2014)
Glyburide is Associated with Attenuated Vasogenic Edema in Stroke Patients
W. Taylor Kimberly et al.
NEUROCRITICAL CARE (2014)
ASA failure Does the combination ASA/clopidogrel confer better long-term vascular protection?
Robert Cote et al.
NEUROLOGY (2014)
Drug Treatment of Acute Ischemic Stroke
Sameer Bansal et al.
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2013)
Clopidogrel with Aspirin in Acute Minor Stroke or Transient Ischemic Attack
Yongjun Wang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Dabigatran versus Warfarin in Patients with Mechanical Heart Valves
John W. Eikelboom et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Edoxaban versus Warfarin in Patients with Atrial Fibrillation
Robert P. Giugliano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Combined Approach to Lysis Utilizing Eptifibatide and Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke-Enhanced Regimen Stroke Trial
Arthur M. Pancioli et al.
STROKE (2013)
Desmoteplase: discovery, insights and opportunities for ischaemic stroke
Robert L. Medcalf
BRITISH JOURNAL OF PHARMACOLOGY (2012)
The future of glycoprotein VI as an antithrombotic target
M. Zahid et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2012)
Vorapaxar for secondary prevention of thrombotic events for patients with previous myocardial infarction: a prespecified subgroup analysis of the TRA 2°P-TIMI 50 trial
Benjamin M. Scirica et al.
LANCET (2012)
Effects of Clopidogrel Added to Aspirin in Patients with Recent Lacunar Stroke
Oscar R. Benavente et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
Pierluigi Tricoci et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Adjunctive and Alternative Approaches to Current Reperfusion Therapy
Andrew D. Barreto et al.
STROKE (2012)
Apixaban versus Warfarin in Patients with Atrial Fibrillation
Christopher B. Granger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
Manesh R. Patel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Inhibition of the intrinsic coagulation pathway factor XI by antisense oligonucleotides: a novel antithrombotic strategy with lowered bleeding risk
Hong Zhang et al.
BLOOD (2010)
Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach The Euro Heart Survey on Atrial Fibrillation
Gregory Y. H. Lip et al.
CHEST (2010)
Thrombin Receptor Antagonists for the Treatment of Atherothrombosis Therapeutic Potential of Vorapaxar and E-5555
Sergio Leonardi et al.
DRUGS (2010)
Comparison of Platelet Function Tests in Predicting Clinical Outcome in Patients Undergoing Coronary Stent Implantation
Nicoline J. Breet et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Asymptomatic Hemorrhagic Transformation of Infarction and Its Relationship With Functional Outcome and Stroke Subtype Assessment From the Tinzaparin in Acute Ischaemic Stroke Trial
Timothy J. England et al.
STROKE (2010)
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials
LANCET (2009)
Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study
Werner Hacke et al.
LANCET NEUROLOGY (2009)
Dabigatran versus Warfarin in Patients with Atrial Fibrillation.
Stuart J. Connolly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke
Ralph L. Sacco et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke
Werner Hacke et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Early hemorrhagic transformation of brain infarction: Rate, predictive factors, and influence on clinical outcome - Results of a prospective multicenter study
Maurizio Paciaroni et al.
STROKE (2008)
The Combined Approach to Lysis Utilizing Eptifibatide and rt-PA in Acute Ischemic Stroke The CLEAR Stroke Trial
Arthur M. Pancioli et al.
STROKE (2008)
Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation
Robert G. Hart et al.
ANNALS OF INTERNAL MEDICINE (2007)
Dose escalation of desmoteplase for acute ischemic stroke (DEDAS) - Evidence of safety and efficacy 3 to 9 hours after stroke onset
AJ Furlan et al.
STROKE (2006)
Predictors of early arterial reocclusion after tissue plasminogen activator-induced recanalization in acute ischemic stroke
M Rubiera et al.
STROKE (2005)
The Desmoteplase In Acute Ischemic Stroke Trial (DIAS) - A phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase
W Hacke et al.
STROKE (2005)
Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial
HC Diener et al.
LANCET (2004)
Comparison of rapidity of coronary recanalization in men with tenecteplase versus alteplase in acute myocardial infarction
AS Binbrek et al.
AMERICAN JOURNAL OF CARDIOLOGY (2004)
Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator
AV Alexandrov et al.
NEUROLOGY (2002)
A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke
JP Mohr et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility
PA Barber et al.
NEUROLOGY (2001)
分享论文
